Previous 10 | Next 10 |
2024-05-01 06:48:13 ET More on Pfizer Is 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1? Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth Pfizer's Doldrums, Just A Bad Case Of COVID-19? Pfizer plans direct-to-consumer platform to ...
2024-05-01 06:01:13 ET Pfizer ( NYSE: PFE ) is reportedly developing a direct-to-consumer (DTC) platform to sell drugs directly to patients.... Read the full article on Seeking Alpha For further details see: Pfizer plans direct-to-consumer platform to sell Covid, mig...
2024-04-30 15:03:39 ET Summary The biotech sector has experienced significant volatility but has returned around the same as the risk-free return from the 10-Year Treasury over the past year. There are two key items that will determine the direction of small and midcap biotech sto...
2024-04-30 14:03:57 ET Pfizer ( NYSE: PFE ) is scheduled to announce Q1 earnings results on Wednesday, May 1st, before market open.... Read the full article on Seeking Alpha For further details see: Pfizer Q1 Earnings Preview: Covid assets to remain the focus this qu...
2024-04-30 09:49:06 ET More on Bristol-Myers, Johnson & Johnson, etc. Bristol Myers Squibb: Tough Times Continue Bristol-Myers Squibb Company (BMY) Q1 2024 Earnings Call Transcript Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off ...
2024-04-30 07:45:00 ET Earnings season is officially here. As per usual, there have already been epic sell-offs and run-ups across well-known names. However, long-term investors know that the best way to view a quarterly earnings report is within the context of an investment thesis rath...
2024-04-30 06:26:54 ET Pfizer ( NYSE: PFE ) and Danish drugmaker Genmab ( GMAB ) announced Monday that the U.S. FDA accepted a supplemental Biologics License Application granting full approval for their cervical cancer therapy, Tivdak (tisotumab vedotin-tftv).... Read ...
2024-04-30 05:50:00 ET I owned shares of Pfizer (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar over 60% in roughly two years was fun. Seeing Pfizer's share price fall nearly 60% from its peak wasn't so fun. Have I been tempted to sell during this major d...
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer Conversion to full approval from accelerated approval is based on positive results from global Phase 3 study demonstrating ...
Company Announcement Full approval based on global Phase 3 study demonstrating overall survival benefit of TIVDAK compared to chemotherapy TIVDAK is the first antibody-drug conjugate in this patient population to have positive overall survival data Genmab A/S (...
News, Short Squeeze, Breakout and More Instantly...
2024-07-25 06:15:00 ET If you're looking to invest in order to get richer, that's great -- because most of us need to be amassing a war chest for retirement (not to mention other financial goals, such as a down payment for a home and college tuition for kids). The simplest, and arguably bes...
2024-07-25 05:05:00 ET Which company is the leader in the burgeoning weight loss drug market? A recent poll found that among the largest drugmakers, Pfizer (NYSE: PFE) is the one Americans associate most with this therapeutic area. That's a surprising finding: Pfizer does not ha...
2024-07-24 10:13:00 ET If there's one thing healthcare giant Pfizer (NYSE: PFE) really needs right now, it's a compelling growth catalyst. This year, the company isn't expecting much in the way of growth and investors are unsure about how strong its long-term prospects are, which ...